Bismeen A. Jadoon

Bismeen A. Jadoon

Auto-generated profile, based on publicly available information

Bismeen A. Jadoon

WHO Consultant, Research Coordinator at ERC-RCOG, Giza, Egypt

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
REReda Mohamed Elbadawy
Reda Mohamed Elbadawy
BJBismeen A. Jadoon
Bismeen A. Jadoon
MMMysara M. Mogahed
Mysara M. Mogahed
MIMohamed E. Ibrahim
Mohamed E. Ibrahim
TETarek S. Essawy
Tarek S. Essawy
MEMona Elawady
Mona Elawady
Objectives. This study evaluated the clinical manifestation of COVID-19 and adverse outcomes in patients with comorbidities (outcome: death). Methods. A comparative follow-up investigation involving 148 confirmed cases of COVID-19 was performed for a month (between April and May 2020) at Qaha Hospital to describe the clinical characteristics and outcomes resulting from comorbidities. Participants were divided into two clusters based on the presence of comorbidities. Group I comprised cases with comorbidities, and Group II included subjects without comorbidity. Survival distributions were outlined for the group with comorbidities after the follow-up period. Results. Fever (74.3%), headache (78.4%), cough (78.4%), sore throat (78.4%), fatigue (78.4%), and shortness of breath (86.5%) were the most prevalent symptoms observed in COVID-19 patients with comorbidities. Such patients also suffered from acute respiratory distress syndrome (37.8%) and pneumonia three times more than patients without comorbidities. The survival distributions were statistically significant (chi-square = 26.06, p ≤ 0.001 ). Conclusion. Multiple comorbidities in COVID-19 patients are linked to severe clinical symptoms, disease complications, and critical disease progression. The presence of one or more comorbidities worsened the survival rate of patients.